Litigation Details for HORIZON PHARMA IRELAND LIMITED v. IGI LABORATORIES, INC. (D.N.J. 2015)
✉ Email this page to a colleague
HORIZON PHARMA IRELAND LIMITED v. IGI LABORATORIES, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-10-27 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-05-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Noel Lawrence Hillman |
| Jury Demand | None | Referred To | Ann Marie Donio |
| Patents | 8,563,613; 9,168,304; 9,168,305 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in HORIZON PHARMA IRELAND LIMITED v. IGI LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for HORIZON PHARMA IRELAND LIMITED v. IGI LABORATORIES, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-10-27 | 1 | vii)(IV), that, inter alia, U.S. Patent 8,563,613 (“the ’613 patent) is invalid, unenforceable and/or…United States Patent Nos. 9,168,304 (“the ’304 patent”) and 9,168,305 (“the ’305 patent”) which cover… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 15. On October 27, 2015, the U.S. Patent and Trademark …, the U.S. Patent and Trademark Office (“USPTO”) duly and legally issued the ’305 patent entitled “Treatment | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
